Volume 10, Number 11—November 2004
Dispatch
Decreased Levofloxacin Susceptibility in Haemophilus influenzae in Children, Hong Kong
Pak Leung Ho*
, Kin Hung Chow*, Gannon C. Mak*, Kenneth W. Tsang*, Yu Lung Lau*, Pak-Leung Ho* , Eileen L. Lai*, and Susan S. Chiu*
, Kin Hung Chow*, Gannon C. Mak*, Kenneth W. Tsang*, Yu Lung Lau*, Pak-Leung Ho* , Eileen L. Lai*, and Susan S. Chiu*
Table 1
Levofloxacin and nalidixic acid MIC distributions of all Haemophilus influenzae strains
| MIC (μg/mL) | No. of strains |
|
|---|---|---|
| Levofloxacin | Nalidixic acid | |
| 0.001875 | 1 | 0 |
| 0.00375 | 1 | 0 |
| 0.0075 | 24 | 0 |
| 0.015 | 464 | 0 |
| 0.03 | 66 | 0 |
| 0.06 | 2 | 0 |
| 0.125 | 5 | 0 |
| 0.5 | 0 | 105 |
| 1 | 0 | 303 |
| 2 | 0 | 147 |
| 4 | 0 | 2 |
| 8 | 0 | 1 |
| 64 | 0 | 4 |
| >128 | 0 | 1 |
Page created: May 03, 2011
Page updated: May 03, 2011
Page reviewed: May 03, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.